Foghorn Therapeutics (FHTX) Prepaid Assets (2019 - 2026)
Foghorn Therapeutics (FHTX) posted quarterly Prepaid Assets of $3.2 million for Q1 2026, down 34.09% year-over-year from $4.8 million in Q1 2025, and up 2.98% quarter-over-quarter from $3.1 million in Q4 2025.
Analysis
Foghorn Therapeutics (FHTX) Prepaid Assets (2019 - 2026) Analysis & Trends
Foghorn Therapeutics' Prepaid Assets history runs 8 years deep, the most recent figure standing at $3.2 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 34.09% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $3.2 million (down 34.09% YoY), while the FY2025 annual figure was $3.1 million, down 47.2% from the prior year.
- Prepaid Assets for Q1 2026 stood at $3.2 million, up from $3.1 million in the prior quarter.
- The five-year high for Prepaid Assets was $6.2 million in Q2 2023, with the low at $2.6 million in Q3 2025.
- The 5-year median for Prepaid Assets is $4.8 million (2025), against an average of $4.7 million.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets surged 57.02% in 2022, then plunged 47.2% in 2025.
- Foghorn Therapeutics' Prepaid Assets stood at $5.6 million in 2022, then grew by 9.34% to $6.1 million in 2023, then dropped by 4.41% to $5.9 million in 2024, then slumped by 47.2% to $3.1 million in 2025, then rose by 2.98% to $3.2 million in 2026.
- Business Quant data shows FHTX's Prepaid Assets at $3.2 million in Q1 2026, $3.1 million in Q4 2025, and $2.6 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 10 | Foghorn Therapeutics | 347.14 Mn | 279.06 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.46 Mn |
| Mar 31, 2026 | 3.18 Mn |
| Dec 31, 2025 | 3.09 Mn |
| Sep 30, 2025 | 2.59 Mn |
| Jun 30, 2025 | 3.93 Mn |
| Mar 31, 2025 | 4.83 Mn |
| Dec 31, 2024 | 5.85 Mn |
| Sep 30, 2024 | 3.84 Mn |
| Jun 30, 2024 | 4.44 Mn |
| Mar 31, 2024 | 4.86 Mn |
| Dec 31, 2023 | 6.12 Mn |
| Sep 30, 2023 | 5.55 Mn |
| Jun 30, 2023 | 6.18 Mn |
| Mar 31, 2023 | 4.73 Mn |
| Dec 31, 2022 | 5.60 Mn |
| Sep 30, 2022 | 4.24 Mn |
| Jun 30, 2022 | 5.34 Mn |
| Mar 31, 2022 | 5.09 Mn |
| Dec 31, 2021 | 5.27 Mn |
| Sep 30, 2021 | 3.11 Mn |